BioAge Labs (BIOA) Non-Current Assets (2023 - 2026)
BioAge Labs (BIOA) posted Non-Current Assets of $5.8 million for Q1 2026, down 28.43% sequentially from $8.1 million in Q4 2025, and down 69.55% YoY from $19.0 million in Q1 2025.
BioAge Labs (BIOA) Non-Current Assets (2023 - 2026) Analysis & Trends
BioAge Labs has reported Non-Current Assets for 4 years, with the latest figure at $5.8 million in Q1 2026.
- Quarterly Non-Current Assets fell 69.55% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.6 million (up 124.07% YoY) and the FY2025 annual result came in at $8.1 million, up 615.83% from the prior year.
- Non-Current Assets eased to $5.8 million in Q1 2026 per BIOA's latest filing, from $8.1 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $20.5 million in Q2 2025 and troughed at $618000.0 in Q4 2023.
- A 4-year average of $8.8 million and a median of $6.9 million in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2025 and 2026: Non-Current Assets surged 1460.39% in 2025, then sank 69.55% in 2026.
- Over 4 years, Non-Current Assets stood at $618000.0 in 2023, then surged by 83.01% to $1.1 million in 2024, then surged by 615.83% to $8.1 million in 2025, then slipped by 28.43% to $5.8 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $5.8 million, $8.1 million, and $14.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | 66.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.62 Mn |
| Mar 31, 2026 | 5.79 Mn |
| Dec 31, 2025 | 8.10 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 20.45 Mn |
| Mar 31, 2025 | 19.03 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 914,000.00 |
| Dec 31, 2023 | 618,000.00 |